Public · no account needed

Biotech catalyst calendar — PDUFA dates, readouts and advisory committees

Every upcoming FDA decision, advisory committee and trial readout we maintain, with the filing it came from, the date at the precision the company stated it, and the cash position behind it.

Event table: 2026-09-22
Filing signals: 2026-09-22
Market links: none matched
Events: 1 in this window

Each block carries its own time. This page was assembled 2026-09-22, which is not evidence that anything under it was refreshed then.

Event type

Date confidence

Public float

Runway vs event

Significance

Catalyst events, Next 60 days (2026-09-22 to 2026-11-21), plus events resolved in the last 7 days · Event table maintained 2026-09-22
Expand	Company	Event	Date	Float	Stake	Runway	Financing	Holders	Insider net	Research	Yours	Calls
	TLSATiziana Life Sciences LtdPhase 2	Phase 2 toplineForalumab (intranasal)Non-active Secondary Progressive Multiple Sclerosis (na-SPMS)identity unresolved	2026-10Month · Company guidedno countdown Countdown: not available. Only an exact date carries a countdown.	Float: not available. No public float has been reported at a usable date.	Stake: not available. Research for this company needs an account. The sample companies are fully interactive without one.	Runway: not available. Cash or burn is missing, so no runway verdict is made.	Financing: not available. No financing filing in the period covered.	Holders: not available. No specialist 13F quarter has been read for this issuer.	Insider net: not available. No open-market insider transaction was filed in the window.	Research probability: not available. This event is not joined to a researched indication.	anonymous non sampleYour probability: Research for this company needs an account. The sample companies are fully interactive without one.	Calls: not available. Nobody has published a call on this event.

Dates are what the company, FDA or the trial registry stated, at the precision they stated them. Nothing here is a prediction of an outcome, and no price, implied move or market probability is collected or shown. The research probability is this model’s own estimate of ultimate approval, carrying the date the research was done.